Cargando…

Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives

Monoclonal antibodies (mAbs) have been known since the 1970s. However, their therapeutic potential in the medical field has recently emerged, with the advancement of manufacturing techniques. Initially exploited mainly in the oncology field, mAbs have become increasingly relevant in Infectious Disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quiros-Roldan, Eugenia, Amadasi, Silvia, Zanella, Isabella, Degli Antoni, Melania, Storti, Samuele, Tiecco, Giorgio, Castelli, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707981/ https://www.ncbi.nlm.nih.gov/pubmed/34959672 http://dx.doi.org/10.3390/ph14121272

Ejemplares similares

Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review
por: Tiecco, Giorgio, et al.
Publicado: (2022)

Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From?
por: Tiecco, Giorgio, et al.
Publicado: (2022)

Omicron BA.2 Lineage, the “Stealth” Variant: Is It Truly a Silent Epidemic? A Literature Review
por: Tiecco, Giorgio, et al.
Publicado: (2022)

A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines
por: Tiecco, Giorgio, et al.
Publicado: (2021)

Explorative study regarding influenza vaccine hesitancy among HIV-infected patients
por: Marchese, Valentina, et al.
Publicado: (2022)

Decrease in new diagnosis of HIV/AIDS in the two years period 2019-2020: Impact of COVID-19 pandemic
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2021)

Non-neutralizing antibodies: Deleterious or propitious during SARS-CoV-2 infection?
por: Zanella, Isabella, et al.
Publicado: (2022)

Syphilis Infections, Reinfections and Serological Response in a Large Italian Sexually Transmitted Disease Centre: A Monocentric Retrospective Study
por: Marchese, Valentina, et al.
Publicado: (2022)

An HIV elite controller patient carrying the homozygous H63D variant in the homeostatic iron regulator gene: A case report
por: Zanella, Isabella, et al.
Publicado: (2021)

The impact of early therapies for COVID-19 on death, hospitalization and persisting symptoms: a retrospective study
por: Bertuccio, Paola, et al.
Publicado: (2023)

Cabotegravir Exposure of Zebrafish (Danio rerio) Embryos Impacts on Neurodevelopment and Behavior
por: Zizioli, Daniela, et al.
Publicado: (2023)

Case report: An occult hepatitis B virus infection reactivation in an HIV/HCV coinfected patient during an immune reconstitution inflammatory syndrome
por: Zaltron, Serena, et al.
Publicado: (2023)

Comparison of Efavirenz and Doravirine Developmental Toxicity in an Embryo Animal Model
por: Zizioli, Daniela, et al.
Publicado: (2023)

Gram-Negative Endogenous Endophthalmitis: A Systematic Review
por: Tiecco, Giorgio, et al.
Publicado: (2022)

An exploratory pilot study on the involvement of APOE, HFE, C9ORF72 variants and comorbidities in neurocognitive and physical performance in a group of HIV-infected people
por: Zanella, Isabella, et al.
Publicado: (2022)

Characteristics of the population with mild COVID-19 symptoms eligible for early treatment attended in a single center in Northern Italy
por: Magro, Paola, et al.
Publicado: (2023)

Human Orf with Immune-Mediated Reactions: A Systematic Review
por: Rossi, Luca, et al.
Publicado: (2023)

Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals 2021, 14, 454
por: Zanella, Isabella, et al.
Publicado: (2021)

Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection
por: Zanella, Isabella, et al.
Publicado: (2021)

Letter to the Editor on “Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev”
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2020)

Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment
por: Magro, Paola, et al.
Publicado: (2021)

The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2017)

The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
por: Quiros Roldan, Eugenia, et al.
Publicado: (2020)

Dalbavancin in Bone and Joint Infections: A Systematic Review
por: Lovatti, Sofia, et al.
Publicado: (2023)

The importance of SHBG and calculated free testosterone for the diagnosis of symptomatic hypogonadism in HIV-infected men: a single-centre real-life experience
por: Pezzaioli, Letizia Chiara, et al.
Publicado: (2020)

Autoantibodies to Interferons in Infectious Diseases
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2023)

Real-life use of Doravirine in treatment-experienced people living with HIV: A multicenter Italian study
por: Mazzitelli, Maria, et al.
Publicado: (2022)

Refractory migraine profile in CGRP‐monoclonal antibodies scenario
por: Silvestro, Marcello, et al.
Publicado: (2021)

Timing and implications for immune response to vaccine in SARS-CoV-2 breakthrough infections
por: Arsuffi, Stefania, et al.
Publicado: (2023)

Immunological Evolution of a Cohort of HIV-2 Infected Patients: Peculiarities of an Underestimated Infection
por: Fumarola, Benedetta, et al.
Publicado: (2022)

COVID-19 Pneumonia with Migratory Pattern in Agammaglobulinemic Patients: A Report of Two Cases and Review of Literature
por: Degli Antoni, Melania, et al.
Publicado: (2023)

Treating Alzheimer’s disease with monoclonal antibodies: current status and outlook for the future
por: Prins, Niels D, et al.
Publicado: (2013)

Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives
por: Lonial, S, et al.
Publicado: (2016)

Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine
por: SHERMAN, DAVID M., et al.
Publicado: (1986)

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
por: Ascierto, Paolo A, et al.
Publicado: (2011)

High frequency of type I interferon auto‐antibodies in a group of middle‐aged HIV‐infected patients: A cross‐sectional exploratory study
por: Imberti, Luisa, et al.
Publicado: (2023)

Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
por: Kardas, Grzegorz, et al.
Publicado: (2022)

Hypogonadism and liver fibrosis in HIV-infected patients
por: Quiros-Roldan, E., et al.
Publicado: (2021)

The pharmacology and therapeutic applications of monoclonal antibodies
por: Castelli, María Sofía, et al.
Publicado: (2019)

Malaria vectors in South America: current and future scenarios
por: Laporta, Gabriel Zorello, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5d8gff7bhuq3pds5eblrufnl5t